Holen Sie sich die Stockscreener-App
70.50
2.19%
-1.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$72.08
Offen:
$70.89
24-Stunden-Volumen:
1.34M
Relative Volume:
0.71
Marktkapitalisierung:
$34.08B
Einnahmen:
$10.63B
Nettoeinkommen (Verlust:
$819.00M
KGV:
42.53
EPS:
1.6577
Netto-Cashflow:
$1.59B
1W Leistung:
-2.10%
1M Leistung:
-0.69%
6M Leistung:
-16.34%
1J Leistung:
-10.66%
1-Tages-Spanne:
$70.48
$71.14
1-Wochen-Bereich:
$70.48
$73.52
52-Wochen-Spanne:
$61.84
$87.64
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Alcon stock edges lower as investors weigh recent performance and upcoming Q3 earnings - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: Exploring A Promising 20.91% Upside Potential - DirectorsTalk Interviews
Alcon stock heads into the open after a modest decline - AD HOC NEWS
Alcon Stock Price Forecast. Should You Buy ALC? - StockInvest.us
Alcon stock trades softer as options activity and Q2 growth shape investor view - AD HOC NEWS
Alcon Market Sentiment - Benzinga España
Alcon stock eases after UNITY M launch and strong Q2 figures - AD HOC NEWS
The Back-to-School Essential Parents Are Overlooking: Eye Exams - Scripps News
Alcon stock dips in Zurich as UNITY M launch follows strong Q2 2026 figures - AD HOC NEWS
Alcon Debuts UNITY M Ophthalmic Surgical Microscope in U.S., Japan - Medical Product Outsourcing
Alcon: A Re-Rating In Eyesight - Seeking Alpha
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control - Business Wire
Are Options Traders Betting on a Big Move in Alcon Stock? - TradingView
Changes in working capital of Alcon AG – BX:2U3 - TradingView
Alcon stock holds near 52 week high after Q2 beat - AD HOC NEWS
Alcon (SWX:ALC), What Is Behind The Fresh Attention? - Yahoo Finance
Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD - Yahoo Finance
Alcon stock holds steady as drug pricing deal and Q2 reset shape outlook - AD HOC NEWS
Alcon stock edges higher as Q2 2026 impairment and earnings reset the outlook - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: A Closer Look At Its 18.37% Potential Upside - DirectorsTalk Interviews
Alcon stock holds steady as latest impairment reshapes its earnings picture - AD HOC NEWS
Alcon stock slips as revenue rises 8.0% in Q2 - AD HOC NEWS
Alcon Rolls Out UNITY CS Platform in Canada - Medical Product Outsourcing
Alcon stock steady as new EUR 500 million notes support growth plans - AD HOC NEWS
Alcon prices €500 million senior notes due 2033 By Investing.com - Investing.com Canada
Alcon prices €500M senior notes at 3.875%, due 2033 - Dealroom
Alcon stock holds steady as Q2 2026 earnings and guidance frame valuation - AD HOC NEWS
Alcon prices €500 million senior notes due 2033 - Investing.com
SGA Exits Alcon (ALC) as Cataract Demand Slows and Competition Rises - AlphaStreet
Alcon stock edges lower as Swiss shares hover around CHF 58.62 after recent gains - AD HOC NEWS
Alcon’s Q2 2026 Growth Shows UNITY Momentum, but Cataract Softness and Implantables Competition Still Matter - AlphaStreet
Alcon Inc. (ALC): Investor Outlook On Its 15.77% Potential Upside - DirectorsTalk Interviews
Alcon stock trades steadily as analyst targets signal upside - AD HOC NEWS
Alcon stock steady after Q2 2026 sales rise 8 percent - AD HOC NEWS
Alcon stock holds after Q2 sales rose 8 percent - Ad-hoc-news.de
Alcon stock holds in mid-$70 range as Q2 2026 sales rise 8 percent - Ad-hoc-news.de
Alcon stock edges higher after Q2 2026 sales rise and steady mid-$70 trading level - Ad-hoc-news.de
Alcon stock holds steady as analysts point to upside from latest market cap and valuation context. - Ad-hoc-news.de
What Makes Alcon (ALC) a Bullish Bet? - Yahoo Finance
Resilient Alcon stock holds near $73 as Q2 2026 sales and profit outpace growth in eye-care segments - Ad-hoc-news.de
World Council of Optometry, Alcon, and IACLE Partner to Advance Dry Eye Education - InvisionMag.com
Alcon stock trades around $73 as Q2 2026 profit growth and dry eye push shape expectations - AD HOC NEWS
Alcon stock holds in the low $70s as Q2 2026 growth and dry eye push shape the outlook - AD HOC NEWS
Deutsche Bank Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $90 - Moomoo
World Council of Optometry, Alcon and IACLE Partner to Advance Dry Eye Education - VisionMonday.com
Alcon (ALC) Q2 2026 Earnings Call Transcript - The Globe and Mail
Alcon stock steadies above $74 as Q2 2026 earnings show mixed profit picture - AD HOC NEWS
Deutsche Bank raises TP for Alcon, but shares down - marketscreener.com
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy (NYSE:ALC) - Seeking Alpha
Alcon Inc. (ALC) Stock Analysis: Robust Revenue Growth And A 15.52% Upside Potential - DirectorsTalk Interviews
Stronger Sales But Weaker Earnings Could Be A Game Changer For Alcon (SWX:ALC) - simplywall.st
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):